News

Aignostics Announces Results for Pathology Foundation Model Developed in Collaboration with Mayo Clinic

13.1.2025

Aignostics takes home prize at The Spark German Digital Awards

15.11.2024

Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI

29.10.2024

Bayer and Aignostics to collaborate on next generation precision oncology

14.3.2024

Aignostics’ foundation model for histopathology takes the lead on key benchmarks

9.1.2024

Aignostics achieves ISO 13485 certification to support clinical research and diagnostics development

20.10.2023

Aignostics and Virchow Laboratories collaborate to offer AI-powered pathology in China

5.6.2023

Aignostics presenting new research and collaborations at AACR 2023

14.4.2023

We welcome Gerald Moeller as new member of our Board of Directors

14.3.2023

Aignostics wins €1.4 million ProFIT Funding

6.3.2023

Aignostics Raises €14 million Series A to Advance AI-powered Pathology

15.9.2022

Aignostics earns ISO 27001 certification for information security

9.8.2022

Aignostics & Ultivue Announce Unique Spatial AI-Powered Imaging Solutions for Translational Medicine

9.3.2022

We are appointing Jessica Riley as our new Chief Business Officer!

1.1.2022

We welcome Emmanuel Blin as our new Chairman of the Board!

18.5.2021

Aignostics raises €5m Seed Round to advance AI-powered pathology

Aignostics closes €5m Seed Round

28.8.2020

Precise diagnostics with AI: BIH Digital Health Accelerator guides Aignostics GmbH through its spin-off

21.4.2020

Machine learning improves the diagnosis of patients with head and neck cancers

12.9.2019

The two faces of intelligent assistants

18.3.2019

When a computer decides on therapy

26.12.2018

Algorithms will not replace pathologists

5.12.2018

Machine Learning in Pathology: Making Complex Data Visible and Interpreting

22.5.2018

Unlock the power of biomedical data.

At Aignostics, we're transforming complex biomedical data into actionable insights that drive innovation in healthcare. Stay connected with us and be the first to learn how we’re shaping the future of medicine through data-driven solutions.